Long-term biventricular support with rotary blood pumps: prospects and pitfalls
Authors:
Open Access
- 30 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 42 (2) , 203-208
Abstract
Congestive heart failure affects 23 million people worldwide, including 7.5 million in North America (670 000 new cases per year) and 7 million in Europe [1]. Since 10% of those over 65 suffer from systolic left ventricular dysfunction, the number of patients with heart failure will double over the next 25 years. At any time, 10% of the heart failure cohort are categorized Stage D with advanced structural heart disease and symptoms at rest, despite detailed medical and cardiac resynchronization therapy. Twenty percent of these are younger than 65 years of age (around 140 000 in both the USA and Europe).Keywords
This publication has 45 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implantsThe Journal of Heart and Lung Transplantation, 2010
- Destination therapy: time for real progressNature Clinical Practice Cardiovascular Medicine, 2008
- Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic DysfunctionJAMA, 2007
- Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureNew England Journal of Medicine, 2006
- Ethics Guidelines for Destination TherapyThe Annals of Thoracic Surgery, 2006
- Coronary revascularization in ischemic cardiomyopathySurgical Clinics of North America, 2004
- Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathyThe Journal of Heart and Lung Transplantation, 2004
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Left ventricular assist system as a bridge to myocardial recoveryThe Annals of Thoracic Surgery, 1999